医学
血栓形成
卵巢癌
静脉血栓形成
抗血栓
低分子肝素
癌症
肺栓塞
内科学
外科
深静脉
动脉栓塞
肿瘤科
心脏病学
栓塞
作者
Jing Chen,Huimin Sun,Minrong Wu,Xiaolin Zhong,Yuqin Zhang
标识
DOI:10.1177/0300060520926742
摘要
Patients with ovarian cancer are often in a hypercoagulable state and have a high risk of venous thrombosis, including deep vein thrombosis and pulmonary embolism. However, arterial thrombosis is relatively rare in ovarian cancer. We report a case a 46-year-old woman with ovarian clear cell carcinoma who developed arterial and venous thrombosis in the lower extremities as the first manifestation. Her arterial thrombosis-related ischemic symptoms were not responsive to anticoagulant treatment of low-molecular-weight heparin, but improved after neoadjuvant chemotherapy and surgery. Therefore, we hypothesize that the optimal therapy for arterial thrombosis in ovarian cancer is treatment for the underlying disease (i.e., ovarian cancer). A thorough investigation is required to determine the relationships between arterial thrombosis and ovarian cancer and antithrombotic treatments for ovarian cancer related-arterial thrombosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI